Your browser is no longer supported. Please, upgrade your browser.
CMRX Chimerix, Inc. daily Stock Chart
Chimerix, Inc.
Index- P/E- EPS (ttm)-1.83 Insider Own1.10% Shs Outstand61.74M Perf Week-5.14%
Market Cap201.34M Forward P/E- EPS next Y-0.25 Insider Trans25.35% Shs Float50.45M Perf Month-0.63%
Income-105.30M PEG- EPS next Q-0.17 Inst Own54.10% Short Float2.48% Perf Quarter20.77%
Sales11.40M P/S17.66 EPS this Y-41.90% Inst Trans0.36% Short Ratio1.87 Perf Half Y81.50%
Book/sh1.64 P/B1.91 EPS next Y66.70% ROA-81.30% Target Price- Perf Year-4.85%
Cash/sh1.61 P/C1.95 EPS next 5Y- ROE-89.20% 52W Range1.19 - 3.88 Perf YTD54.68%
Dividend- P/FCF- EPS past 5Y-2.40% ROI-105.20% 52W High-19.18% Beta1.92
Dividend %- Quick Ratio16.00 Sales past 5Y25.40% Gross Margin- 52W Low163.87% ATR0.21
Employees43 Current Ratio16.00 Sales Q/Q-50.00% Oper. Margin- RSI (14)44.33 Volatility6.21% 7.03%
OptionableYes Debt/Eq0.00 EPS Q/Q51.50% Profit Margin- Rel Volume0.97 Prev Close3.11
ShortableYes LT Debt/Eq0.00 EarningsMay 07 BMO Payout- Avg Volume667.68K Price3.14
Recom2.30 SMA20-4.85% SMA50-2.77% SMA20041.88% Volume649,291 Change0.96%
Feb-14-18Downgrade JP Morgan Neutral → Underweight
Feb-02-18Initiated H.C. Wainwright Buy $10
Aug-09-16Reiterated FBR Capital Mkt Perform $9 → $8
Feb-23-16Reiterated FBR Capital Mkt Perform $14 → $10
Feb-23-16Downgrade Morgan Stanley Equal-Weight → Underweight
Feb-23-16Downgrade Barclays Overweight → Equal Weight $12 → $6
Feb-22-16Downgrade Citigroup Buy → Neutral
Dec-29-15Downgrade JP Morgan Overweight → Neutral $65 → $15
Dec-28-15Reiterated Piper Jaffray Overweight $63 → $10
Dec-28-15Downgrade FBR Capital Outperform → Mkt Perform $73 → $14
Dec-17-15Initiated UBS Buy $55
Oct-05-15Downgrade Morgan Stanley Overweight → Equal-Weight
Sep-03-15Initiated Citigroup Buy
Aug-18-15Initiated FBR Capital Outperform $73
Aug-06-15Reiterated Brean Capital Buy $50 → $57
May-11-15Reiterated Brean Capital Buy $45 → $50
Mar-04-15Initiated Barclays Overweight $55
Feb-12-15Reiterated Stifel Buy $47 → $57
Dec-31-14Reiterated Brean Capital Buy $33 → $45
Jul-08-14Resumed Brean Capital Buy $33
Aug-03-20 08:00AM  
Jul-15-20 12:22PM  
Jul-05-20 02:43PM  
Jun-22-20 07:00AM  
Jun-18-20 08:00AM  
May-28-20 08:00AM  
May-12-20 06:47AM  
May-07-20 10:25AM  
May-02-20 08:40AM  
Apr-29-20 07:00AM  
Apr-28-20 04:30PM  
Mar-26-20 08:18AM  
Mar-18-20 06:26AM  
Feb-28-20 12:00PM  
Feb-26-20 08:00AM  
Feb-25-20 07:00AM  
Feb-24-20 08:00AM  
Feb-18-20 08:00AM  
Feb-06-20 07:04AM  
Feb-05-20 11:52AM  
Jan-29-20 08:00AM  
Jan-03-20 11:30AM  
Dec-23-19 06:12AM  
Dec-16-19 01:04AM  
Dec-14-19 08:59PM  
Dec-10-19 07:30AM  
Dec-04-19 01:01AM  
Nov-22-19 12:02AM  
Nov-07-19 06:19AM  
Nov-05-19 07:00AM  
Nov-04-19 04:01PM  
Oct-29-19 08:00AM  
Oct-02-19 08:47AM  
Oct-01-19 08:10AM  
Sep-30-19 07:30PM  
Sep-27-19 08:00AM  
Aug-27-19 01:13PM  
Aug-08-19 09:35AM  
Aug-07-19 10:30AM  
Aug-05-19 07:55AM  
Jul-31-19 07:00AM  
Jul-12-19 03:07PM  
Jun-28-19 06:41PM  
May-17-19 08:18AM  
May-16-19 09:11AM  
May-09-19 09:25AM  
May-02-19 04:01PM  
Apr-29-19 10:31AM  
Apr-12-19 01:43PM  
Apr-09-19 11:21AM  
Apr-08-19 05:00PM  
Apr-05-19 02:14PM  
Mar-26-19 06:30PM  
Mar-07-19 12:24PM  
Mar-05-19 07:00AM  
Mar-04-19 08:00AM  
Feb-26-19 08:00AM  
Feb-22-19 08:00AM  
Feb-14-19 08:15AM  
Feb-11-19 07:55AM  
Feb-06-19 02:20PM  
Jan-30-19 11:51AM  
Jan-24-19 10:17AM  
Jan-18-19 06:36AM  
Jan-17-19 09:38AM  
Jan-04-19 07:30AM  
Dec-27-18 09:23AM  
Dec-22-18 04:43AM  
Dec-18-18 08:35AM  
Dec-12-18 11:26AM  
Dec-03-18 07:55AM  
Nov-08-18 07:44AM  
Nov-07-18 08:14AM  
Nov-05-18 02:29PM  
Nov-01-18 08:00AM  
Oct-27-18 01:00PM  
Oct-24-18 07:25AM  
Oct-11-18 04:01PM  
Oct-05-18 07:00AM  
Oct-04-18 07:00AM  
Sep-26-18 07:30AM  
Sep-04-18 02:38PM  
Aug-29-18 07:00AM  
Aug-28-18 07:30AM  
Aug-08-18 09:50AM  
Chimerix, Inc., a development-stage biopharmaceutical company, focuses on accelerating the advancement of various medicines that impact in the lives of patients living with cancer and other serious diseases. Its clinical stage development programs include dociparstat sodium (DSTAT), a potential first-in-class glycosaminoglycan compound derived from porcine heparin that has low anticoagulant activity but retains the ability to inhibit activities of key proteins implicated in the retention and viability of acute myeloid leukemia blasts and leukemic stem cells in the bone marrow during chemotherapy; and brincidofovir (BCV), an antiviral drug candidate in development as a medical countermeasure for smallpox. The company has license agreements with Biomedical Advanced Research and Development Authority for the development of brincidofovir for use in the treatment of smallpox; Cantex Pharmaceuticals, Inc. to develop and commercialize a glycosaminoglycan compound; SymBio Pharmaceuticals to develop, manufacture, and commercialize BCV for various human indications; and University of Michigan to research, develop, manufacture, and commercialize various products. Chimerix, Inc. was founded in 2000 and is headquartered in Durham, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Andriole Michael T.Chief Business OfficerMar 16Buy1.4333,30047,522149,729Mar 17 11:58 AM
MIDDLETON FRED ADirectorMar 12Buy1.4050,00069,900197,523Mar 16 12:19 PM
Sherman Michael A.Chief Executive OfficerMar 12Buy1.4572,995105,653102,995Mar 16 12:51 PM
Nichols GarrettChief Medical OfficerFeb 10Sale1.688,80514,830260,066Feb 11 04:19 PM
Nichols GarrettChief Medical OfficerFeb 07Sale1.702,5504,335268,871Feb 11 04:19 PM
Jakeman DavidPrincipal Accounting OfficerFeb 07Sale1.702,2903,89387,876Feb 11 04:16 PM
Nichols GarrettChief Medical OfficerJan 07Sale2.1530,68066,045271,421Jan 08 08:18 PM
MIDDLETON FRED ADirectorNov 13Buy1.8230,00054,567147,523Nov 13 04:14 PM
MIDDLETON FRED ADirectorNov 11Buy1.6620,00033,190117,523Nov 13 04:14 PM
Meyer Robert J.DirectorNov 06Buy1.5810,00015,79710,000Nov 06 05:00 PM
Andriole Michael T.Chief Business OfficerNov 06Buy1.56100,000156,000100,000Nov 07 12:45 PM
CNSL Consolidated Communications Holdings, Inc. daily Stock Chart
Consolidated Communications Holdings, Inc.
Index- P/E- EPS (ttm)-0.29 Insider Own1.70% Shs Outstand73.04M Perf Week18.91%
Market Cap536.03M Forward P/E11.87 EPS next Y0.61 Insider Trans0.00% Shs Float71.65M Perf Month13.15%
Income-20.80M PEG- EPS next Q0.17 Inst Own78.90% Short Float9.84% Perf Quarter40.25%
Sales1.34B P/S0.40 EPS this Y63.40% Inst Trans-0.18% Short Ratio14.46 Perf Half Y47.85%
Book/sh4.88 P/B1.48 EPS next Y-18.58% ROA-0.60% Target Price6.50 Perf Year40.94%
Cash/sh0.19 P/C38.02 EPS next 5Y2.00% ROE-6.00% 52W Range3.24 - 7.51 Perf YTD86.34%
Dividend- P/FCF10.41 EPS past 5Y-23.30% ROI3.40% 52W High-3.73% Beta1.19
Dividend %- Quick Ratio0.80 Sales past 5Y16.00% Gross Margin57.00% 52W Low123.15% ATR0.36
Employees3400 Current Ratio0.80 Sales Q/Q-3.80% Oper. Margin6.40% RSI (14)63.54 Volatility7.93% 5.12%
OptionableYes Debt/Eq6.44 EPS Q/Q297.20% Profit Margin-1.60% Rel Volume1.37 Prev Close7.30
ShortableYes LT Debt/Eq6.36 EarningsJul 30 BMO Payout- Avg Volume487.49K Price7.23
Recom3.20 SMA2013.48% SMA5013.32% SMA20040.55% Volume668,775 Change-0.96%
Apr-26-19Upgrade Wells Fargo Market Perform → Outperform $8
Apr-26-19Downgrade Guggenheim Neutral → Sell $8 → $4
Feb-19-19Downgrade Raymond James Strong Buy → Outperform
Jan-08-19Downgrade Wells Fargo Outperform → Market Perform
Mar-13-18Initiated Guggenheim Neutral $11
Jun-09-17Upgrade Raymond James Outperform → Strong Buy
Jun-07-17Upgrade Citigroup Sell → Neutral
Mar-29-17Resumed Wells Fargo Outperform
Mar-10-17Upgrade Raymond James Mkt Perform → Outperform
Dec-06-16Upgrade Raymond James Underperform → Mkt Perform
Aug-05-16Downgrade Raymond James Mkt Perform → Underperform
Jun-27-16Downgrade Drexel Hamilton Buy → Hold
Apr-04-16Downgrade DA Davidson Neutral → Underperform $22
May-08-15Upgrade Drexel Hamilton Hold → Buy
Jan-20-15Reiterated DA Davidson Neutral $28 → $26
Feb-08-12Upgrade DA Davidson Underperform → Neutral $15.50 → $19
Apr-06-10Downgrade RBC Capital Mkts Outperform → Sector Perform
Feb-24-10Initiated RBC Capital Mkts Outperform
Sep-14-09Downgrade Soleil Buy → Hold $14.50 → $15
Sep-14-09Downgrade DA Davidson Buy → Neutral $15.50
Jul-31-20 10:26AM  
Jul-30-20 08:00AM  
Jul-29-20 10:00AM  
Jul-28-20 04:00PM  
Jul-21-20 08:00AM  
Jul-14-20 02:00PM  
Jun-29-20 02:00PM  
Jun-16-20 07:18PM  
Jun-08-20 11:57AM  
Jun-04-20 02:00PM  
May-21-20 08:09AM  
May-18-20 12:55PM  
May-06-20 03:00PM  
Apr-30-20 04:31PM  
Apr-29-20 08:00AM  
Apr-27-20 07:15AM  
Apr-22-20 09:00AM  
Apr-08-20 05:00PM  
Apr-07-20 10:00AM  
Mar-31-20 09:00AM  
Mar-03-20 09:00AM  
Feb-20-20 08:00AM  
Feb-13-20 11:32AM  
Feb-04-20 11:50AM  
Jan-28-20 01:43PM  
Jan-21-20 01:00PM  
Dec-16-19 09:00AM  
Dec-08-19 03:15PM  
Dec-02-19 01:00PM  
Nov-25-19 09:00AM  
Nov-05-19 01:53PM  
Oct-31-19 02:12PM  
Oct-30-19 07:20AM  
Oct-25-19 12:08PM  
Oct-23-19 10:49AM  
Oct-10-19 04:22PM  
Oct-01-19 09:57AM  
Sep-30-19 11:16PM  
Sep-27-19 09:00AM  
Sep-26-19 05:45PM  
Sep-25-19 02:45PM  
Sep-24-19 07:23AM  
Sep-20-19 11:51AM  
Sep-19-19 05:45PM  
Sep-16-19 10:46AM  
Sep-11-19 08:30AM  
Sep-06-19 09:49AM  
Sep-05-19 11:47AM  
Sep-03-19 11:27AM  
Sep-02-19 09:10AM  
Aug-30-19 03:12PM  
Aug-26-19 08:14AM  
Aug-23-19 10:23AM  
Aug-22-19 02:55PM  
Aug-21-19 05:46PM  
Aug-14-19 09:00AM  
Aug-12-19 09:00AM  
Aug-07-19 02:27PM  
Aug-05-19 07:55PM  
Aug-01-19 09:45AM  
Jul-30-19 09:51AM  
Jul-26-19 05:45PM  
Jul-25-19 10:33AM  
Jul-19-19 05:45PM  
Jul-12-19 05:58PM  
Jul-11-19 05:45PM  
Jul-09-19 09:00AM  
Jul-05-19 08:40AM  
Jul-04-19 09:00AM  
Jul-02-19 07:02PM  
Jul-01-19 09:51AM  
Jun-28-19 07:55PM  
Jun-25-19 07:05AM  
Jun-12-19 12:56PM  
Jun-11-19 06:35PM  
Jun-03-19 08:13AM  
May-30-19 09:07AM  
May-22-19 07:54AM  
May-21-19 06:10AM  
May-14-19 09:35AM  
May-13-19 08:17AM  
May-10-19 07:27AM  
Consolidated Communications Holdings, Inc., together with its subsidiaries, provides telecommunications services to business and residential customers in the United States. It offers high-speed broadband Internet access and voice over Internet protocol (VoIP) phone services; commercial data connectivity services in select markets, including a portfolio of Ethernet services, software defined wide area network, multi-protocol label switching, and private line services; and wholesale services to regional and national interexchange and wireless carriers, including cellular backhaul, dark fiber, and other fiber transport solutions. The company also provides voice services that include local phone and long-distance service packages for business customers; and sells business equipment and provides related hardware and maintenance support, video, and other miscellaneous services. In addition, it offers video services, which consist of high-definition television, digital video recorders (DVR), and/or a whole home DVR; other in-demand streaming content, including DIRECTV, DIRECTV NOW, fuboTV, Philo, HBO NOW, FlixFling, and VEMOX; and network access services, including interstate and intrastate switched access, network special access, and end user access. Further, the company engages in telephone directory publishing, video advertising, billing and support services, and other miscellaneous activities. As of December 31, 2019, it had approximately 836,000 voice connections, 784,000 data connections, and 84,000 video connections. The company serves customers in consumer, commercial, and carrier channels. Consolidated Communications Holdings, Inc. was founded in 1894 and is headquartered in Mattoon, Illinois.
FFG FBL Financial Group, Inc. daily Stock Chart
FBL Financial Group, Inc.
Index- P/E9.59 EPS (ttm)3.61 Insider Own0.10% Shs Outstand24.76M Perf Week-2.01%
Market Cap856.65M Forward P/E7.05 EPS next Y4.91 Insider Trans-2.73% Shs Float9.82M Perf Month0.14%
Income89.50M PEG0.68 EPS next Q1.13 Inst Own31.20% Short Float0.89% Perf Quarter-10.77%
Sales718.70M P/S1.19 EPS this Y35.60% Inst Trans-0.18% Short Ratio1.87 Perf Half Y-33.72%
Book/sh53.76 P/B0.64 EPS next Y12.87% ROA0.90% Target Price47.00 Perf Year-39.13%
Cash/sh0.71 P/C48.95 EPS next 5Y14.20% ROE6.30% 52W Range29.01 - 59.81 Perf YTD-38.23%
Dividend2.00 P/FCF8.80 EPS past 5Y3.00% ROI8.10% 52W High-42.08% Beta0.25
Dividend %5.77% Quick Ratio- Sales past 5Y2.30% Gross Margin- 52W Low19.41% ATR1.16
Employees1751 Current Ratio- Sales Q/Q-27.80% Oper. Margin14.10% RSI (14)44.47 Volatility2.52% 3.08%
OptionableYes Debt/Eq0.08 EPS Q/Q-107.50% Profit Margin12.50% Rel Volume0.42 Prev Close34.78
ShortableYes LT Debt/Eq0.07 EarningsAug 06 AMC Payout53.70% Avg Volume46.76K Price34.64
Recom2.00 SMA20-2.00% SMA50-3.22% SMA200-23.16% Volume19,643 Change-0.40%
Nov-05-19Upgrade Raymond James Underperform → Mkt Perform
Aug-06-19Downgrade Raymond James Mkt Perform → Underperform
Aug-09-17Upgrade Raymond James Underperform → Mkt Perform
Jan-20-17Downgrade Raymond James Mkt Perform → Underperform
Aug-16-13Reiterated FBR Capital Mkt Perform $39 → $42
Mar-08-13Reiterated FBR Capital Mkt Perform $32 → $37
Jul-11-12Reiterated FBR Capital Mkt Perform $35 → $32
Apr-09-12Downgrade FBR Capital Outperform → Mkt Perform $38 → $35
Feb-04-11Reiterated FBR Capital Outperform $32 → $34
Aug-20-10Initiated FBR Capital Outperform $28
Apr-21-09Initiated Keefe Bruyette Mkt Perform $7
May-12-08Upgrade Keefe Bruyette Mkt Perform → Outperform
Jul-30-20 12:33PM  
Jul-27-20 01:47PM  
Jul-06-20 04:15PM  
Jun-23-20 02:31PM  
Jun-21-20 10:48PM  
Jun-16-20 05:30PM  
Jun-09-20 04:15PM  
Jun-07-20 06:28PM  
May-18-20 09:15AM  
May-10-20 09:37AM  
May-09-20 08:00AM  
May-07-20 04:15PM  
May-06-20 01:00PM  
Apr-30-20 12:33PM  
Apr-27-20 03:31PM  
Apr-26-20 10:52AM  
Apr-23-20 11:02PM  
Apr-17-20 11:50AM  
Apr-16-20 04:15PM  
Mar-31-20 09:10AM  
Mar-18-20 12:52PM  
Mar-12-20 07:42AM  
Mar-08-20 08:47AM  
Feb-26-20 04:15PM  
Feb-24-20 04:15PM  
Feb-18-20 06:45AM  
Feb-17-20 04:15PM  
Feb-10-20 11:38AM  
Feb-06-20 07:35PM  
Jan-30-20 12:31PM  
Jan-13-20 06:40AM  
Jan-07-20 04:15PM  
Dec-16-19 06:10AM  
Nov-29-19 06:15AM  
Nov-20-19 04:15PM  
Nov-18-19 11:48PM  
Oct-31-19 06:35PM  
Oct-26-19 01:19PM  
Oct-24-19 10:32AM  
Oct-15-19 07:09AM  
Oct-07-19 04:15PM  
Sep-12-19 08:37AM  
Sep-09-19 06:05AM  
Aug-22-19 09:15AM  
Aug-19-19 04:15PM  
Aug-13-19 09:48AM  
Aug-06-19 11:05PM  
Aug-05-19 02:08PM  
Aug-01-19 04:15PM  
Jul-17-19 04:15PM  
Jul-13-19 10:44AM  
Jul-08-19 04:15PM  
Jun-13-19 01:14PM  
May-21-19 03:42PM  
May-16-19 04:15PM  
May-08-19 01:03PM  
May-03-19 01:41PM  
May-02-19 04:15PM  
Apr-15-19 04:15PM  
Apr-04-19 04:15PM  
Mar-29-19 09:15AM  
Mar-07-19 08:36AM  
Mar-06-19 04:15PM  
Mar-01-19 02:22PM  
Feb-28-19 09:23AM  
Feb-27-19 04:48PM  
Feb-13-19 01:29AM  
Feb-08-19 01:26PM  
Feb-07-19 04:15PM  
Jan-31-19 10:31AM  
Jan-07-19 04:15PM  
Dec-26-18 08:55AM  
Nov-27-18 06:54AM  
Nov-26-18 07:38AM  
Nov-16-18 09:28PM  
Nov-14-18 04:15PM  
Nov-02-18 07:30AM  
Nov-01-18 04:15PM  
Oct-04-18 04:15PM  
Sep-08-18 10:06AM  
Sep-01-18 10:52AM  
Aug-27-18 09:15AM  
Aug-23-18 04:15PM  
Aug-16-18 01:35PM  
Aug-06-18 04:15PM  
Aug-03-18 09:25AM  
Aug-02-18 04:15PM  
Jul-25-18 08:15AM  
FBL Financial Group, Inc., through its subsidiaries, sells individual life insurance and annuity products. The Annuity segment sells various traditional annuity products that primarily consist of fixed rate and indexed annuities, and supplementary contracts. The Life Insurance segment offers whole life, term life, and universal life policies. The company is also involved in the property-casualty business; and provision of wealth management, investment advisory, and marketing and distribution services for the sale of mutual funds and insurance products, as well as leasing services. It markets its products to Farm Bureau members, and other individuals and businesses through exclusive agents and agency managers under the consumer brand name of Farm Bureau Financial Services in the Midwestern and Western sections of the United States. The company was founded in 1945 and is headquartered in West Des Moines, Iowa.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Aldridge Anthony JamesChief Accounting OfficerJun 02Option Exercise23.8669516,583845Jun 03 05:03 PM
Aldridge Anthony JamesChief Accounting OfficerJun 02Sale36.0469525,051150Jun 03 05:03 PM
NATH Nathan's Famous, Inc. daily Stock Chart
Nathan's Famous, Inc.
Index- P/E16.10 EPS (ttm)3.19 Insider Own36.68% Shs Outstand4.21M Perf Week-2.41%
Market Cap214.05M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float2.82M Perf Month-13.66%
Income13.40M PEG- EPS next Q- Inst Own48.50% Short Float2.17% Perf Quarter-10.50%
Sales103.30M P/S2.07 EPS this Y-37.70% Inst Trans0.25% Short Ratio8.42 Perf Half Y-21.27%
Book/sh-15.78 P/B- EPS next Y- ROA12.70% Target Price- Perf Year-26.37%
Cash/sh18.49 P/C2.78 EPS next 5Y- ROE-20.80% 52W Range39.01 - 82.18 Perf YTD-27.58%
Dividend1.40 P/FCF38.92 EPS past 5Y4.60% ROI28.30% 52W High-37.54% Beta0.10
Dividend %2.73% Quick Ratio6.10 Sales past 5Y0.80% Gross Margin46.00% 52W Low31.58% ATR2.41
Employees120 Current Ratio6.10 Sales Q/Q-1.80% Oper. Margin26.30% RSI (14)42.72 Volatility3.60% 4.13%
OptionableNo Debt/Eq- EPS Q/Q23.20% Profit Margin13.00% Rel Volume1.60 Prev Close50.93
ShortableYes LT Debt/Eq- Earnings- Payout43.90% Avg Volume7.26K Price51.33
Recom- SMA20-3.64% SMA50-7.69% SMA200-18.99% Volume11,630 Change0.79%
Jul-01-20 09:29AM  
Jun-12-20 08:30AM  
Jun-10-20 03:17PM  
May-25-20 12:06PM  
May-04-20 01:49PM  
Apr-19-20 10:20AM  
Mar-23-20 07:17AM  
Mar-12-20 04:00PM  
Feb-07-20 08:30AM  
Jan-20-20 09:02AM  
Dec-30-19 11:01AM  
Dec-22-19 06:10PM  
Dec-19-19 01:08PM  
Dec-18-19 12:08PM  
Nov-08-19 08:30AM  
Nov-07-19 03:08PM  
Oct-24-19 11:56AM  
Oct-01-19 03:49PM  
Sep-16-19 06:52PM  
Sep-09-19 08:06AM  
Aug-19-19 06:06AM  
Aug-09-19 08:30AM  
Aug-05-19 12:13PM  
Jul-09-19 12:37PM  
Jul-03-19 04:19PM  
Jun-18-19 11:36AM  
Jun-14-19 08:30AM  
Jun-12-19 11:37AM  
May-16-19 08:15AM  
May-14-19 09:36AM  
Apr-09-19 01:57PM  
Apr-04-19 03:02PM  
Feb-21-19 02:19PM  
Feb-06-19 08:15AM  
Feb-01-19 11:30AM  
Jan-16-19 02:06PM  
Dec-17-18 01:38PM  
Nov-07-18 07:30AM  
Nov-05-18 02:25PM  
Nov-02-18 08:38AM  
Oct-05-18 07:55AM  
Oct-04-18 09:09PM  
Sep-14-18 11:11AM  
Sep-03-18 12:58PM  
Aug-14-18 05:26PM  
Aug-03-18 08:43AM  
Jul-25-18 08:25AM  
Jul-04-18 02:46PM  
Jul-03-18 03:19PM  
Jun-22-18 01:12PM  
Jun-19-18 07:10AM  
Jun-08-18 02:29PM  
Jun-07-18 03:38PM  
May-18-18 08:30AM  
Apr-20-18 08:18PM  
Apr-13-18 04:39PM  
Mar-21-18 07:55AM  
Feb-02-18 04:41PM  
Feb-01-18 07:59AM  
Jan-19-18 08:10AM  
Dec-25-17 12:11PM  
Dec-17-17 02:44PM  
Dec-14-17 01:55PM  
Nov-28-17 12:51PM  
Nov-27-17 10:04AM  
Nov-17-17 12:30PM  
Nov-03-17 11:15AM  
Nov-01-17 04:10PM  
Oct-18-17 05:00PM  
Oct-17-17 04:10PM  
Oct-09-17 06:59PM  
Sep-07-17 01:36PM  
Sep-05-17 04:26PM  
Sep-03-17 12:42PM  
Sep-01-17 11:20PM  
Aug-07-17 01:39PM  
Aug-05-17 12:02AM  
Aug-04-17 08:30AM  
Jul-06-17 08:30AM  
Jul-05-17 12:12AM  
Jul-04-17 01:38PM  
Jul-03-17 11:22AM  
Jul-02-17 11:35PM  
Jun-30-17 01:47PM  
Jun-28-17 04:49PM  
Nathan's Famous, Inc., together with its subsidiaries, operates in the foodservice industry. The company owns and franchises restaurants under the Nathan's Famous brand name, as well as sells products bearing the Nathan's Famous trademarks through various channels of distribution. It also has license agreements for the manufacture, distribution, marketing, and sale of Nathan's Famous branded hot dogs, sausages, and corned beef products in refrigerated consumer packages to be resold through retail channels, such as supermarkets, groceries, mass merchandisers, and club stores; and other Nathan's Famous branded refrigerated meat products in consumer packages to be resold through retail channels. In addition, the company has license agreements to manufacture Nathan's Famous branded hot dog and sausage products in bulk for use in the food service industry; for supplying Nathan's Famous natural casing and skinless hot dogs in bulk for use in the Nathan's Famous restaurant system; to manufacture proprietary spices; to manufacture and sell various products, including mustard, salsa, sauerkraut, and pickles; to produce and sell French fries and onion rings for retail sale; and to manufacture and sell miniature bagel dogs, franks-in-a-blanket, and other hors d'oeuvres through club stores, supermarkets, and other retail food stores. Further, the company sells Nathan's products directly to end users or to various foodservice distributors, as well as provides Arthur Treacher's brand fish fillets. As of March 29, 2020, its restaurant system consisted of four company-owned units in the New York City metropolitan area; and 216 franchised units in 21 states and nine foreign countries. Nathan's Famous, Inc. was founded in 1916 and is based in Jericho, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DEVOS RONALD GVP-Fin, CFO, SecretaryDec 13Sale71.9013,709985,6770Dec 16 04:54 PM
GENSON BRIAN SDirectorNov 15Sale76.752,991229,56216,942Nov 18 05:45 PM
GENSON BRIAN SDirectorNov 14Sale80.001,00980,72019,933Nov 18 05:45 PM
PFNX Pfenex Inc. daily Stock Chart
Pfenex Inc.
Index- P/E- EPS (ttm)-0.19 Insider Own0.30% Shs Outstand33.15M Perf Week-3.03%
Market Cap259.42M Forward P/E15.29 EPS next Y0.48 Insider Trans0.00% Shs Float31.88M Perf Month-11.42%
Income-5.40M PEG- EPS next Q-0.28 Inst Own88.70% Short Float4.53% Perf Quarter32.55%
Sales40.60M P/S6.39 EPS this Y102.30% Inst Trans-1.19% Short Ratio4.80 Perf Half Y-32.32%
Book/sh2.51 P/B2.94 EPS next Y157.80% ROA-7.00% Target Price- Perf Year16.61%
Cash/sh1.86 P/C3.95 EPS next 5Y14.60% ROE-8.30% 52W Range5.26 - 14.00 Perf YTD-32.88%
Dividend- P/FCF- EPS past 5Y15.60% ROI1.10% 52W High-47.36% Beta0.89
Dividend %- Quick Ratio10.40 Sales past 5Y36.40% Gross Margin89.90% 52W Low40.11% ATR0.44
Employees85 Current Ratio10.40 Sales Q/Q-91.10% Oper. Margin-14.00% RSI (14)42.36 Volatility5.03% 5.29%
OptionableYes Debt/Eq0.00 EPS Q/Q-59.10% Profit Margin-13.40% Rel Volume0.88 Prev Close7.09
ShortableYes LT Debt/Eq0.00 EarningsAug 06 AMC Payout- Avg Volume300.96K Price7.37
Recom1.60 SMA20-6.43% SMA50-8.34% SMA200-21.19% Volume266,284 Change3.95%
Jun-01-20Resumed Oppenheimer Outperform $9 → $10
Apr-23-20Initiated Oppenheimer Outperform $9
Feb-14-20Initiated SunTrust Buy $18
Oct-25-19Initiated Cantor Fitzgerald Overweight $20
Aug-09-16Reiterated Mizuho Buy $22 → $18
May-24-16Reiterated Barclays Overweight $28 → $14
May-18-15Initiated Barclays Overweight $28
Feb-17-15Reiterated Mizuho Buy $12 → $16
Jul-30-20 12:33PM  
Jul-20-20 08:30AM  
Jun-27-20 01:21PM  
Jun-26-20 02:05PM  
Jun-16-20 04:35PM  
Jun-12-20 08:00AM  
Jun-08-20 06:31PM  
Jun-05-20 09:00AM  
Jun-04-20 10:39PM  
Jun-03-20 04:53PM  
May-27-20 12:23PM  
May-25-20 03:50PM  
May-18-20 07:21AM  
May-07-20 04:05PM  
May-05-20 06:15PM  
Apr-24-20 04:05PM  
Apr-17-20 10:00AM  
Apr-16-20 01:18PM  
Apr-14-20 05:04PM  
Apr-09-20 06:30PM  
Mar-16-20 07:47AM  
Mar-11-20 04:05PM  
Feb-26-20 05:03PM  
Jan-31-20 10:42AM  
Jan-15-20 12:15AM  
Jan-08-20 08:00AM  
Dec-19-19 10:21PM  
Dec-18-19 08:00AM  
Nov-20-19 04:10PM  
Nov-19-19 04:10PM  
Nov-13-19 04:40PM  
Nov-07-19 07:45PM  
Nov-06-19 04:10PM  
Oct-31-19 10:34AM  
Oct-24-19 04:30PM  
Oct-14-19 03:05PM  
Oct-11-19 10:45AM  
Oct-07-19 05:00AM  
Oct-03-19 03:49PM  
Sep-16-19 04:05PM  
Sep-10-19 04:05PM  
Sep-05-19 04:05PM  
Sep-04-19 04:05PM  
Aug-17-19 06:24PM  
Aug-08-19 07:30PM  
Aug-01-19 10:33AM  
Jul-25-19 04:10PM  
Jul-19-19 12:42PM  
Jun-25-19 08:59PM  
Jun-20-19 07:52AM  
Jun-18-19 05:45PM  
Jun-05-19 04:05PM  
May-30-19 08:01AM  
May-21-19 08:06AM  
May-09-19 07:35PM  
May-02-19 10:33AM  
Apr-25-19 04:05PM  
Apr-23-19 08:05AM  
Apr-11-19 08:05AM  
Mar-27-19 04:05PM  
Mar-26-19 04:05PM  
Mar-18-19 04:05PM  
Mar-15-19 08:29AM  
Mar-13-19 11:40PM  
Mar-11-19 05:30PM  
Mar-06-19 04:05PM  
Mar-04-19 08:05AM  
Feb-28-19 08:05AM  
Feb-27-19 04:05PM  
Feb-25-19 04:05PM  
Feb-19-19 08:05AM  
Dec-10-18 08:00AM  
Nov-26-18 08:20AM  
Nov-20-18 07:32AM  
Nov-07-18 04:05PM  
Oct-25-18 04:05PM  
Oct-01-18 04:05PM  
Sep-21-18 04:29PM  
Sep-11-18 08:00AM  
Sep-04-18 08:00AM  
Aug-23-18 09:50PM  
Aug-16-18 04:05PM  
Aug-08-18 04:05PM  
Jul-25-18 04:05PM  
Jul-12-18 08:00AM  
Jun-22-18 05:00PM  
Pfenex Inc., a clinical-stage development and licensing biotechnology company, focuses on developing protein therapies for unmet patient needs. Its lead product candidate include PF708, a therapeutic equivalent drug candidate to Forteo (teriparatide) for the treatment of osteoporosis. The company also develops PF743, a recombinant crisantaspase; PF745, a recombinant crisantaspase with half-life extension technology; and PF810, a peptide based next generation therapeutic which is in preclinical development, as well as offers sparX-1 (PF753) and sparX-2 (PF754). In addition, it has license and supply agreements for CRM197, a non-toxic mutant of diphtheria toxin. Pfenex Inc. is headquartered in San Diego, California.
QTS QTS Realty Trust, Inc. daily Stock Chart
QTS Realty Trust, Inc.
Index- P/E- EPS (ttm)-0.07 Insider Own0.80% Shs Outstand61.30M Perf Week3.38%
Market Cap4.38B Forward P/E391.64 EPS next Y0.18 Insider Trans-42.36% Shs Float60.81M Perf Month8.71%
Income-4.70M PEG- EPS next Q-0.02 Inst Own- Short Float17.79% Perf Quarter11.05%
Sales480.90M P/S9.11 EPS this Y80.40% Inst Trans1.58% Short Ratio13.10 Perf Half Y24.43%
Book/sh16.39 P/B4.37 EPS next Y460.00% ROA-0.10% Target Price73.78 Perf Year55.91%
Cash/sh2.81 P/C25.47 EPS next 5Y- ROE-0.50% 52W Range42.64 - 72.21 Perf YTD32.06%
Dividend1.88 P/FCF151.08 EPS past 5Y-17.20% ROI2.50% 52W High-0.75% Beta0.55
Dividend %2.62% Quick Ratio- Sales past 5Y17.20% Gross Margin64.50% 52W Low68.08% ATR1.73
Employees612 Current Ratio- Sales Q/Q12.10% Oper. Margin12.40% RSI (14)72.92 Volatility2.81% 2.40%
OptionableYes Debt/Eq1.75 EPS Q/Q-105.40% Profit Margin-1.00% Rel Volume0.36 Prev Close71.95
ShortableYes LT Debt/Eq1.75 EarningsJul 27 AMC Payout- Avg Volume825.71K Price71.67
Recom2.00 SMA206.39% SMA509.67% SMA20022.64% Volume300,034 Change-0.39%
Jul-29-20Upgrade Raymond James Mkt Perform → Outperform $74
Jul-15-20Initiated Barclays Overweight $73
Jun-05-20Resumed Deutsche Bank Hold $69
May-04-20Upgrade Jefferies Hold → Buy $75
Apr-29-20Downgrade Raymond James Outperform → Mkt Perform
Apr-16-20Initiated Cowen Outperform $69
Oct-29-19Upgrade JP Morgan Neutral → Overweight $50 → $65
Jul-31-19Upgrade Raymond James Mkt Perform → Outperform $50
Oct-31-18Upgrade Guggenheim Neutral → Buy
Sep-20-18Initiated Berenberg Hold $50
Aug-08-18Upgrade Credit Suisse Underperform → Neutral
Aug-02-18Upgrade Raymond James Underperform → Mkt Perform
Jul-17-18Resumed Stifel Buy $48
Apr-09-18Initiated MoffettNathanson Neutral $40
Mar-16-18Upgrade Goldman Neutral → Buy
Feb-23-18Downgrade Jefferies Buy → Hold
Feb-22-18Downgrade Guggenheim Buy → Neutral
Feb-21-18Downgrade Raymond James Outperform → Underperform
Jan-17-18Downgrade Credit Suisse Neutral → Underperform
Jun-30-17Initiated Credit Suisse Neutral $54
Aug-03-20 01:10PM  
Jul-29-20 04:05PM  
Jul-28-20 09:00PM  
Jul-27-20 05:25PM  
Jul-22-20 09:00AM  
Jul-02-20 09:00AM  
Jun-30-20 09:00AM  
Jun-18-20 03:33PM  
Jun-16-20 09:00AM  
Jun-12-20 02:07AM  
Jun-11-20 09:00AM  
Jun-10-20 09:00AM  
Jun-04-20 09:00AM  
Jun-01-20 10:21PM  
May-28-20 09:00AM  
May-26-20 09:00AM  
May-21-20 06:23PM  
May-20-20 09:14AM  
May-13-20 09:00AM  
May-08-20 09:04AM  
Apr-28-20 09:01PM  
Apr-27-20 08:15PM  
Apr-24-20 10:21AM  
Apr-22-20 12:45PM  
Apr-17-20 12:15PM  
Apr-16-20 04:05PM  
Apr-09-20 09:00AM  
Apr-05-20 04:30PM  
Apr-02-20 09:00AM  
Apr-01-20 06:30AM  
Mar-30-20 08:46AM  
Mar-26-20 09:00AM  
Mar-11-20 09:00AM  
Mar-02-20 04:05PM  
Feb-26-20 06:18AM  
Feb-25-20 09:00AM  
Feb-21-20 04:05PM  
Feb-18-20 04:13PM  
Feb-12-20 09:00AM  
Feb-06-20 09:00AM  
Jan-22-20 09:00AM  
Jan-21-20 04:05PM  
Jan-16-20 09:00AM  
Jan-14-20 09:00AM  
Dec-18-19 09:00AM  
Dec-06-19 09:05AM  
Nov-25-19 04:05PM  
Nov-21-19 04:05PM  
Nov-14-19 09:00AM  
Nov-12-19 09:00AM  
Nov-09-19 08:03PM  
Nov-05-19 07:23AM  
Nov-04-19 08:45PM  
Oct-31-19 09:00AM  
Oct-29-19 12:58PM  
Oct-25-19 10:18AM  
Oct-23-19 01:26PM  
Oct-22-19 09:00AM  
Oct-08-19 09:00AM  
Oct-01-19 04:05PM  
Sep-27-19 06:01AM  
Sep-26-19 09:00AM  
Sep-24-19 04:05PM  
Sep-16-19 04:25PM  
Sep-09-19 09:00AM  
Aug-27-19 12:03PM  
Aug-21-19 09:00AM  
Aug-12-19 03:19PM  
Aug-07-19 09:34AM  
Aug-05-19 04:05PM  
Aug-02-19 06:41AM  
Aug-01-19 09:00AM  
Jul-29-19 06:05PM  
Jul-24-19 09:32AM  
Jul-22-19 09:53AM  
Jul-17-19 09:00AM  
Jul-11-19 09:00AM  
Jul-02-19 09:00AM  
Jul-01-19 09:00AM  
Jun-21-19 12:24PM  
Jun-20-19 02:52PM  
QTS Realty Trust, Inc. (NYSE: QTS) is a leading provider of data center solutions across a diverse footprint spanning more than 6 million square feet of owned data center space throughout primarily North America and Europe. Through its software-defined technology platform, QTS is able to deliver secure, compliant infrastructure solutions, robust connectivity and premium customer service to leading hyperscale technology companies, enterprises, and government entities. QTS owns, operates or manages 25 data centers and supports more than 1,200 customers primarily in North America and Europe.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Goza Shirley E.SecretaryJul 31Option Exercise34.0315,417524,64142,447Jul 31 05:28 PM
Goza Shirley E.SecretaryJul 31Sale70.7315,4171,090,45327,030Jul 31 05:28 PM
SCHAFER WILLIAM HEVP -- Finance and AccountingMay 11Sale65.1820,0001,303,64416,307May 12 04:44 PM
Williams Chad L.Chief Executive OfficerMay 06Sale65.15241,80815,753,791191,342May 08 05:08 PM
Bloom Steven CChief People OfficerApr 30Sale64.227,767498,81726,367May 04 04:09 PM
SCHAFER WILLIAM HEVP -- Finance and AccountingMar 05Sale58.2617,5001,019,62932,243Mar 09 04:39 PM
Goza Shirley E.SecretaryMar 04Option Exercise30.5021,400652,71944,163Mar 06 05:24 PM
Goza Shirley E.SecretaryMar 04Sale59.8939,3602,357,23519,425Mar 06 05:24 PM
Greaves Jon DChief Technology OfficerFeb 26Sale61.5012,500768,75026,250Feb 28 04:54 PM
Marino PeterDirectorFeb 21Sale63.155,000315,75014,758Feb 25 04:56 PM
SCHAFER WILLIAM HEVP -- Finance and AccountingNov 27Sale53.555,000267,76951,265Nov 29 04:58 PM
Berson Jeffrey H.Chief Financial OfficerNov 22Sale50.8849,5222,519,69462,797Nov 25 05:29 PM
Al-Rawashdeh MazenDirectorNov 18Option Exercise42.811,53265,5855,205Nov 18 05:21 PM
REHBERGER WAYNE MDirectorNov 18Buy27.191,20032,6321,200Nov 19 05:17 PM
Al-Rawashdeh MazenDirectorNov 18Sale52.012,408125,2442,797Nov 18 05:21 PM
Marino PeterDirectorNov 14Sale51.403,521180,97619,758Nov 18 05:19 PM
TRAHANAS PHILIP PDirectorNov 12Sale50.8360,0003,049,52415,633Nov 13 04:16 PM
SCHAFER WILLIAM HEVP -- Finance and AccountingNov 11Sale51.067,500382,93156,265Nov 13 04:13 PM
REHBERGER WAYNE MDirectorAug 05Buy45.501,10050,0503,046Aug 07 08:28 AM
SAFT Safety Insurance Group, Inc. daily Stock Chart
Safety Insurance Group, Inc.
Index- P/E17.10 EPS (ttm)4.39 Insider Own1.70% Shs Outstand15.23M Perf Week-0.25%
Market Cap1.14B Forward P/E16.66 EPS next Y4.50 Insider Trans14.67% Shs Float14.58M Perf Month0.08%
Income67.30M PEG1.14 EPS next Q2.30 Inst Own83.90% Short Float1.42% Perf Quarter-4.50%
Sales837.00M P/S1.36 EPS this Y19.00% Inst Trans0.19% Short Ratio3.47 Perf Half Y-19.11%
Book/sh50.04 P/B1.50 EPS next Y-30.23% ROA3.40% Target Price- Perf Year-22.65%
Cash/sh2.74 P/C27.33 EPS next 5Y15.00% ROE8.60% 52W Range65.45 - 103.96 Perf YTD-18.96%
Dividend3.60 P/FCF42.58 EPS past 5Y10.60% ROI12.10% 52W High-27.87% Beta0.37
Dividend %4.80% Quick Ratio- Sales past 5Y2.40% Gross Margin- 52W Low14.58% ATR1.82
Employees609 Current Ratio- Sales Q/Q-17.90% Oper. Margin9.80% RSI (14)45.00 Volatility1.67% 2.26%
OptionableYes Debt/Eq0.04 EPS Q/Q-106.70% Profit Margin8.00% Rel Volume0.45 Prev Close75.67
ShortableYes LT Debt/Eq0.04 Earnings- Payout79.10% Avg Volume59.85K Price74.99
Recom- SMA20-1.66% SMA50-1.82% SMA200-12.63% Volume27,215 Change-0.90%
Mar-08-18Upgrade Compass Point Sell → Neutral
Oct-16-17Downgrade Compass Point Neutral → Sell
Aug-05-16Reiterated Compass Point Neutral $58 → $60
May-04-16Reiterated Compass Point Neutral $57 → $58
Nov-04-15Reiterated Compass Point Neutral $58 → $57
May-06-15Reiterated Compass Point Neutral $63 → $58
Nov-05-14Downgrade Compass Point Buy → Neutral $63 → $63
Aug-28-14Initiated Compass Point Buy $63
Mar-12-07Upgrade Keefe Bruyette Mkt Perform → Outperform
Jul-05-20 02:27PM  
May-27-20 11:23AM  
May-06-20 04:05PM  
May-05-20 10:38AM  
Apr-27-20 02:26PM  
Apr-13-20 02:55PM  
Mar-27-20 08:32AM  
Feb-26-20 04:05PM  
Feb-24-20 05:49AM  
Feb-14-20 10:00AM  
Feb-11-20 12:52PM  
Jan-12-20 08:56AM  
Dec-16-19 07:53AM  
Dec-12-19 11:30AM  
Nov-05-19 11:58AM  
Oct-30-19 04:05PM  
Oct-26-19 12:36PM  
Oct-10-19 12:48PM  
Sep-17-19 10:35AM  
Aug-25-19 09:53AM  
Aug-08-19 05:57AM  
Aug-01-19 09:17AM  
Jul-31-19 04:05PM  
Jul-18-19 10:49AM  
May-30-19 11:59AM  
May-06-19 08:16AM  
May-02-19 10:00AM  
May-01-19 06:34PM  
Apr-23-19 02:31PM  
Apr-10-19 03:21PM  
Feb-28-19 06:48AM  
Feb-27-19 04:30PM  
Feb-26-19 04:05PM  
Feb-21-19 01:25PM  
Feb-15-19 04:05PM  
Feb-12-19 08:20AM  
Jan-17-19 08:04AM  
Dec-18-18 07:35AM  
Dec-08-18 06:48PM  
Nov-17-18 09:22AM  
Nov-12-18 08:00AM  
Nov-05-18 12:53PM  
Oct-31-18 04:37PM  
Oct-12-18 09:08AM  
Oct-11-18 08:15AM  
Aug-28-18 07:44AM  
Aug-07-18 08:20AM  
Aug-02-18 05:37PM  
Aug-01-18 06:10PM  
Jun-21-18 01:36PM  
May-07-18 11:25AM  
May-02-18 06:21PM  
May-01-18 08:00AM  
Apr-18-18 08:27AM  
Mar-22-18 08:30AM  
Mar-17-18 09:02AM  
Feb-28-18 09:48PM  
Feb-26-18 05:27PM  
Feb-24-18 03:53PM  
Feb-20-18 06:25AM  
Feb-15-18 04:05PM  
Jan-22-18 07:55AM  
Dec-26-17 12:03PM  
Dec-21-17 09:12AM  
Dec-18-17 07:47AM  
Dec-11-17 08:02AM  
Dec-08-17 02:11PM  
Dec-07-17 07:44AM  
Dec-05-17 11:15AM  
Nov-11-17 10:38AM  
Nov-03-17 12:31PM  
Nov-02-17 02:00PM  
Nov-01-17 06:21PM  
Sep-25-17 09:47AM  
Sep-12-17 08:16PM  
Sep-11-17 08:34AM  
Aug-29-17 07:40AM  
Aug-09-17 01:05PM  
Aug-03-17 01:46PM  
Aug-02-17 10:08PM  
Jul-03-17 09:15AM  
Jun-12-17 02:25PM  
Jun-09-17 09:38AM  
Jun-05-17 12:34PM  
May-31-17 11:23AM  
May-10-17 04:01PM  
May-05-17 04:59PM  
Safety Insurance Group, Inc. provides private passenger and commercial automobile, and homeowner insurance in the United States. The company's private passenger automobile policies offer coverage for bodily injury and property damage to others, no-fault personal injury coverage for the insured/insured's car occupants, and physical damage coverage for an insured's own vehicle for collision or other perils. It also provides commercial automobile policies that offer insurance for commercial vehicles used for business purposes, including private passenger-type vehicles, trucks, tractors and trailers, insure individual vehicles, and commercial fleets; and homeowners policies, which provide coverage for homes, condominiums, and apartments for losses to a dwelling and its contents from various perils, and coverage for liability to others arising from ownership or occupancy. In addition, the company offers business owners policies that cover apartments and residential condominiums, restaurants, office condominiums, processing and services businesses, special trade contractors, and wholesalers. Further, it provides personal umbrella policies, which provide personal excess liability coverage over and above the limits of individual automobile, watercraft, and homeowner's insurance policies; and commercial umbrella policies, as well as underwrites dwelling fire insurance for non-owner occupied residences. Additionally, the company offers inland marine coverage for homeowners and business owner policies; and watercraft coverage for small and medium sized pleasure crafts. It distributes its products through independent agents. The company was formerly known as Safety Holdings Inc and changed its name to Safety Insurance Group, Inc. in April 2002. Safety Insurance Group, Inc. was founded in 1979 and is based in Boston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lindeberg Frederic HDirectorMar 27Buy76.151,00076,15018,000Mar 30 07:42 AM
SRB Corp10% OwnerMar 23Buy66.8286257,5991,582,095Mar 24 07:44 PM
SRB Corp10% OwnerMar 20Buy71.3217,5901,254,5191,581,233Mar 23 12:07 PM
SRB Corp10% OwnerMar 18Buy73.7517,1101,261,8631,563,643Mar 19 09:47 PM
Berry JamesVP - UnderwritingMar 02Sale81.393,599292,93527,243Mar 03 04:55 PM
Varga Stephen AlbertVP - MISNov 25Sale98.2590088,42519,428Nov 26 06:18 AM
TREE LendingTree, Inc. daily Stock Chart
LendingTree, Inc.
Index- P/E90.51 EPS (ttm)3.98 Insider Own5.20% Shs Outstand12.96M Perf Week2.05%
Market Cap4.85B Forward P/E74.38 EPS next Y4.85 Insider Trans-6.36% Shs Float7.88M Perf Month21.92%
Income57.90M PEG4.53 EPS next Q-0.04 Inst Own82.00% Short Float27.39% Perf Quarter46.91%
Sales1.13B P/S4.30 EPS this Y-65.30% Inst Trans1.42% Short Ratio13.18 Perf Half Y17.06%
Book/sh32.69 P/B11.03 EPS next Y102.89% ROA3.30% Target Price304.91 Perf Year12.49%
Cash/sh3.81 P/C94.63 EPS next 5Y20.00% ROE8.20% 52W Range135.72 - 392.74 Perf YTD18.80%
Dividend- P/FCF36.51 EPS past 5Y129.70% ROI8.00% 52W High-8.21% Beta2.25
Dividend %- Quick Ratio0.60 Sales past 5Y45.90% Gross Margin94.20% 52W Low165.62% ATR12.78
Employees1095 Current Ratio0.60 Sales Q/Q7.90% Oper. Margin6.50% RSI (14)70.15 Volatility3.36% 3.72%
OptionableYes Debt/Eq0.94 EPS Q/Q- Profit Margin2.90% Rel Volume1.12 Prev Close346.29
ShortableYes LT Debt/Eq0.63 EarningsAug 04 BMO Payout0.00% Avg Volume163.61K Price360.50
Recom1.90 SMA209.14% SMA5021.10% SMA20024.89% Volume183,090 Change4.10%
Jul-17-20Reiterated Needham Buy $275 → $375
Jul-17-20Downgrade JP Morgan Overweight → Neutral $250 → $280
May-06-20Downgrade Compass Point Buy → Neutral $238
Apr-15-20Upgrade SunTrust Hold → Buy $330
Apr-15-20Reiterated Needham Buy $375 → $220
Mar-13-20Upgrade Northland Capital Market Perform → Outperform $350
Mar-12-20Upgrade RBC Capital Mkts Sector Perform → Outperform $343 → $332
Dec-30-19Upgrade Compass Point Neutral → Buy $340
Dec-12-19Reiterated Oppenheimer Outperform $410 → $380
Nov-22-19Initiated JP Morgan Overweight $405
Sep-03-19Upgrade UBS Neutral → Buy $355 → $395
Jul-26-19Reiterated BofA/Merrill Buy $420 → $390
Jul-25-19Upgrade Susquehanna Neutral → Positive
Jul-02-19Downgrade RBC Capital Mkts Outperform → Sector Perform $415
Apr-30-19Reiterated Compass Point Buy $305 → $345
Apr-29-19Reiterated BofA/Merrill Buy $400 → $420
Feb-28-19Downgrade UBS Buy → Neutral $305 → $320
Feb-26-19Downgrade Northland Capital Outperform → Market Perform
Dec-28-18Upgrade Northland Capital Market Perform → Outperform
Dec-19-18Initiated Needham Buy $300
Aug-03-20 01:10PM  
Jul-30-20 12:53PM  
Jul-28-20 02:56PM  
Jul-27-20 12:20PM  
Jul-23-20 04:45PM  
Jul-22-20 11:30AM  
Jul-21-20 11:23PM  
Jul-20-20 04:02PM  
Jul-17-20 02:33PM  
Jul-16-20 04:37PM  
Jul-09-20 09:49AM  
Jul-08-20 09:03AM  
Jul-02-20 01:39PM  
Jul-01-20 11:52AM  
Jun-30-20 11:07AM  
Jun-25-20 10:20AM  
Jun-24-20 01:27PM  
Jun-22-20 11:37AM  
Jun-19-20 10:40AM  
Jun-17-20 06:01AM  
Jun-09-20 12:19PM  
Jun-04-20 11:31AM  
Jun-02-20 08:20PM  
May-29-20 09:48AM  
May-28-20 12:38PM  
May-27-20 11:14AM  
May-26-20 01:56PM  
May-20-20 01:45PM  
May-19-20 02:05PM  
May-17-20 08:05AM  
May-13-20 02:58PM  
May-06-20 07:05AM  
May-05-20 10:45AM  
May-04-20 11:13AM  
Apr-30-20 08:00AM  
Apr-29-20 11:03AM  
Apr-28-20 12:33PM  
Apr-23-20 12:19PM  
Apr-22-20 11:15AM  
Apr-21-20 08:05AM  
Apr-20-20 12:28PM  
Apr-17-20 12:30PM  
Apr-16-20 04:30PM  
Apr-15-20 12:05PM  
Apr-14-20 04:17PM  
Apr-13-20 10:04AM  
Apr-09-20 09:01AM  
Apr-08-20 09:34AM  
Apr-07-20 10:32AM  
Apr-06-20 03:11PM  
Apr-02-20 08:01AM  
Mar-31-20 12:17PM  
Mar-30-20 01:03PM  
Mar-27-20 03:52PM  
Mar-26-20 01:53PM  
Mar-25-20 06:00AM  
Mar-24-20 01:03PM  
Mar-19-20 02:55PM  
Mar-18-20 01:35PM  
Mar-17-20 08:58AM  
Mar-16-20 08:59PM  
LendingTree, Inc., through its subsidiary, LendingTree, LLC, operates online consumer platform in the United States. It operates through Home, Consumer, and Insurance segments. The company's Home segment offers purchase mortgage, refinance mortgage, reverse mortgage, and home equity loans; lines of credit; and real estate brokerage services. Its Consumer segment provides credit cards; personal, small business, student, and auto loans; deposit accounts; and other credit products, such as credit repair and debt settlement services. The company's Insurance segment includes information, tools, and access to insurance quote products, including home and automobile, through which consumers are matched with insurance lead aggregators to obtain insurance offers. It also operates CompareCards, an online source for side-by-side credit card comparison shopping; SimpleTuition, an online marketing platform for student loans; MagnifyMoney, a consumer facing media property that offers editorial content, expert commentary, tools, and resources; SnapCap, an online platform, which connects business owners with lenders; ValuePenguin, a personal finance website that offers consumers objective analysis;, a marketplace for insurance comparison; and Student Loan Hero, a personal finance website dedicated to helping student loan borrowers manage their student debt. The company was formerly known as, Inc. and changed its name to LendingTree, Inc. in January 2015. LendingTree, Inc. was founded in 1996 and is headquartered in Charlotte, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Salvage NeilPresidentJul 17Option Exercise223.9024,9105,577,34926,935Jul 21 03:32 PM
Salvage NeilPresidentJul 17Sale325.0024,9108,095,7502,025Jul 21 03:32 PM
Salvage NeilPresidentJun 15Option Exercise78.0215,3591,198,30319,949Jun 17 04:37 PM
Salvage NeilPresidentJun 15Sale268.5518,8575,064,0382,025Jun 17 04:37 PM
Davidson Thomas M JRDirectorJun 10Option Exercise0.002460978Jun 12 02:25 PM
Henderson RobinDirectorJun 10Option Exercise0.0024601,880Jun 12 02:22 PM
Sarasvathy SarasDirectorJun 10Option Exercise0.0024602,153Jun 12 02:18 PM
OZONIAN STEVENDirectorJun 10Option Exercise0.0024603,623Jun 12 02:14 PM
Dalporto GabrielDirectorJun 10Option Exercise0.002460452Jun 11 12:26 PM
Moriarty J DChief Financial OfficerJun 05Option Exercise0.007,13607,335Jun 08 12:42 PM
DeCristo Valentyna S.Sr. VP and Co-General CounselMay 28Option Exercise112.15353,925104Jun 01 06:32 PM
DeCristo Valentyna S.Sr. VP and Co-General CounselMay 28Sale268.9710427,9730Jun 01 06:32 PM
Salvage NeilPresidentMay 08Sale241.233,593866,7395,523May 12 05:27 PM
Olmstead JillChief Human Resources OfficerMar 01Option Exercise0.001,64801,635Mar 02 05:27 PM
DeCristo Valentyna S.Sr. VP and Co-General CounselFeb 22Option Exercise0.0042084Feb 25 05:17 PM
Quinn Ryan S.Sr. VP and Co-General CounselFeb 21Option Exercise0.00420148Feb 25 04:16 PM
DeCristo Valentyna S.Sr. VP and Co-General CounselFeb 21Option Exercise0.0052051Feb 25 05:17 PM
Dalporto GabrielDirectorFeb 16Option Exercise0.00190206Feb 19 02:17 PM
Shumate CarlaChief Accounting OfficerFeb 16Option Exercise0.0035203,009Feb 19 02:16 PM
Quinn Ryan S.Sr. VP and Co-General CounselFeb 07Option Exercise0.00660130Feb 11 11:59 AM
Quinn Ryan S.Sr. VP and Co-General CounselJan 31Option Exercise0.0028064Feb 03 06:48 PM
HORAN PETERDirectorNov 11Sale364.82500182,41018,423Nov 13 05:51 PM
HORAN PETERDirectorNov 05Sale383.34300115,00218,923Nov 13 05:51 PM
HORAN PETERDirectorNov 04Sale386.48300115,94319,223Nov 06 05:13 PM
OZONIAN STEVENDirectorNov 01Sale362.74975353,6753,377Nov 05 03:32 PM
Salvage NeilPresidentOct 22Option Exercise0.006,327011,945Oct 24 04:48 PM
Moriarty J DChief Financial OfficerAug 30Option Exercise0.003600360Sep 03 10:52 AM
Sharma SushilChief Product OfficerAug 09Option Exercise229.151,688386,8058,097Aug 13 04:23 PM
Sharma SushilChief Product OfficerAug 09Sale317.032,128674,6405,969Aug 13 04:23 PM
HORAN PETERDirectorAug 07Sale312.651,000312,65419,523Aug 12 09:55 AM
USPH U.S. Physical Therapy, Inc. daily Stock Chart
U.S. Physical Therapy, Inc.
Index- P/E36.61 EPS (ttm)2.26 Insider Own1.60% Shs Outstand12.80M Perf Week-1.47%
Market Cap1.06B Forward P/E33.63 EPS next Y2.46 Insider Trans-4.81% Shs Float12.57M Perf Month2.23%
Income28.80M PEG3.05 EPS next Q-0.18 Inst Own- Short Float8.74% Perf Quarter17.43%
Sales478.50M P/S2.22 EPS this Y87.00% Inst Trans-1.91% Short Ratio9.85 Perf Half Y-30.44%
Book/sh18.84 P/B4.39 EPS next Y297.73% ROA5.00% Target Price79.75 Perf Year-35.27%
Cash/sh6.96 P/C11.87 EPS next 5Y12.00% ROE12.20% 52W Range45.13 - 148.48 Perf YTD-27.71%
Dividend1.28 P/FCF22.54 EPS past 5Y9.40% ROI18.50% 52W High-44.33% Beta1.28
Dividend %1.55% Quick Ratio2.10 Sales past 5Y9.60% Gross Margin22.00% 52W Low83.16% ATR2.90
Employees5400 Current Ratio2.10 Sales Q/Q-3.00% Oper. Margin11.70% RSI (14)53.75 Volatility2.95% 3.30%
OptionableYes Debt/Eq0.49 EPS Q/Q-48.70% Profit Margin6.00% Rel Volume0.58 Prev Close83.06
ShortableYes LT Debt/Eq0.49 EarningsAug 06 BMO Payout52.70% Avg Volume111.48K Price82.66
Recom2.60 SMA202.45% SMA504.64% SMA200-14.99% Volume64,807 Change-0.48%
Jun-08-20Reiterated Barrington Research Outperform $84 → $95
Apr-30-20Downgrade Sidoti Buy → Neutral
Mar-11-20Upgrade Sidoti Neutral → Buy $128
Feb-28-20Reiterated Barrington Research Outperform $130 → $120
Nov-08-19Upgrade Barrington Research Mkt Perform → Outperform
Mar-08-19Initiated William Blair Outperform
Nov-03-17Downgrade Barrington Research Outperform → Mkt Perform
Sep-08-17Upgrade Sidoti Neutral → Buy
Jul-03-17Upgrade Barrington Research Mkt Perform → Outperform $68
Mar-17-17Downgrade Barrington Research Outperform → Mkt Perform
Nov-04-16Upgrade Barrington Research Mkt Perform → Outperform $61
Aug-05-16Downgrade Barrington Research Outperform → Mkt Perform
May-06-16Upgrade Barrington Research Mkt Perform → Outperform $58
Mar-01-16Downgrade Jefferies Buy → Hold
Nov-06-15Downgrade Barrington Research Outperform → Mkt Perform
May-06-15Upgrade Barrington Research Mkt Perform → Outperform
Dec-12-13Reiterated Dougherty & Company Buy $35 → $40
Aug-23-13Reiterated Dougherty & Company Buy $30 → $35
Jan-14-13Reiterated Dougherty & Company Buy $34 → $30
Jul-09-10Initiated JMP Securities Mkt Outperform $24
Jul-30-20 12:34PM  
Jul-14-20 01:19PM  
Jul-05-20 06:46PM  
Jun-28-20 10:18PM  
Jun-23-20 02:38PM  
Jun-12-20 11:40AM  
May-25-20 07:51AM  
May-21-20 06:00PM  
May-18-20 09:25AM  
May-14-20 12:30PM  
Apr-30-20 12:34PM  
Apr-16-20 09:50AM  
Apr-10-20 10:29AM  
Mar-23-20 01:26AM  
Mar-18-20 11:40AM  
Mar-17-20 09:59AM  
Mar-09-20 06:58AM  
Mar-02-20 09:01AM  
Feb-27-20 09:45AM  
Feb-20-20 12:31PM  
Feb-12-20 01:10PM  
Feb-11-20 12:00PM  
Feb-10-20 11:23AM  
Jan-21-20 11:00AM  
Jan-17-20 02:34PM  
Dec-19-19 09:45PM  
Dec-17-19 02:03PM  
Nov-26-19 01:37AM  
Nov-22-19 08:44AM  
Nov-14-19 01:00PM  
Nov-08-19 10:00AM  
Nov-07-19 09:25AM  
Oct-31-19 03:31PM  
Oct-26-19 01:23PM  
Oct-16-19 11:23AM  
Oct-08-19 10:00AM  
Oct-01-19 09:43AM  
Sep-23-19 01:00PM  
Sep-10-19 06:04AM  
Sep-02-19 10:16PM  
Aug-26-19 10:00AM  
Aug-19-19 09:15PM  
Aug-15-19 07:15PM  
Aug-09-19 07:32AM  
Aug-08-19 04:24PM  
Aug-01-19 10:33AM  
Jul-26-19 08:19AM  
Jul-08-19 02:00PM  
Jul-03-19 12:20PM  
Jul-01-19 04:20PM  
Jun-28-19 06:03PM  
Jun-26-19 09:40AM  
Jun-06-19 02:00PM  
May-31-19 08:59AM  
May-29-19 03:00PM  
May-23-19 09:10AM  
May-22-19 09:32AM  
May-20-19 11:00AM  
May-16-19 10:00AM  
May-06-19 09:17AM  
May-03-19 08:10AM  
May-02-19 02:41PM  
Apr-25-19 10:33AM  
Apr-11-19 07:00AM  
Apr-08-19 11:00AM  
Apr-01-19 07:35AM  
Mar-25-19 11:00AM  
Mar-14-19 02:00PM  
Mar-11-19 02:30PM  
Mar-07-19 03:41PM  
Feb-28-19 11:14AM  
Feb-13-19 09:30AM  
Feb-08-19 08:29AM  
Feb-01-19 03:57PM  
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The company provides industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors As of March 14, 2019, it operated 592 outpatient physical therapy clinics in 42 states; and managed 28 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The company was founded in 1990 and is based in Houston, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BROOKNER MARK JDirectorJun 05Sale86.981,200104,37618,437Jun 05 05:03 PM
BROOKNER MARK JDirectorJun 04Sale79.2337129,39419,637Jun 05 07:46 AM
BROOKNER MARK JDirectorJun 03Sale79.141,02981,43120,008Jun 05 07:46 AM
REEVE GRAHAM D.COOMay 28Sale78.351,00078,3505,519Jun 01 06:03 PM
BROOKNER MARK JDirectorMay 28Sale78.0781363,47121,037May 29 04:30 PM
Chapman Harry SDirectorMar 18Sale54.027,000378,14039,400Mar 19 10:52 AM
Swanson Regg E.DirectorMar 17Buy61.001,00061,0006,596Mar 18 10:46 AM
Swanson Regg E.DirectorMar 13Buy85.681,00085,6765,596Mar 16 01:06 PM
MCAFEE LAWRANCE WChief Financial OfficerMar 05Sale107.583,000322,74023,524Mar 05 04:50 PM
Swanson Regg E.DirectorFeb 28Buy100.712,000201,4204,596Feb 28 06:30 PM
BROOKNER MARK JDirectorDec 06Sale116.731,000116,73021,850Dec 10 03:39 PM
Gilmartin Kathleen ADirectorDec 05Buy114.0050057,0004,600Dec 06 10:17 AM
BROOKNER MARK JDirectorNov 26Sale116.001,000116,00024,350Nov 29 12:39 PM
MCAFEE LAWRANCE WChief Financial OfficerNov 25Sale113.521,598181,40519,728Nov 26 12:05 PM
MCAFEE LAWRANCE WChief Financial OfficerNov 22Sale116.4240246,80121,326Nov 26 12:05 PM
REEVE GRAHAM D.COONov 22Sale116.0647655,2453,839Nov 25 12:10 PM
BROOKNER MARK JDirectorNov 21Sale116.251,000116,25025,350Nov 22 05:03 PM
Chapman Harry SDirectorNov 11Buy117.002,400280,80046,400Nov 13 01:59 PM
READING CHRISTOPHER JChief Executive OfficerAug 19Sale135.124,899661,95362,058Aug 19 06:21 PM
BROOKNER MARK JDirectorAug 16Sale134.251,000134,25026,350Aug 19 03:22 PM
READING CHRISTOPHER JChief Executive OfficerAug 16Sale135.071,500202,60566,957Aug 19 06:21 PM
READING CHRISTOPHER JChief Executive OfficerAug 15Sale135.3960181,36968,457Aug 19 06:21 PM
BROOKNER MARK JDirectorAug 15Sale135.132,000270,26027,350Aug 19 03:22 PM
McDowell GlennChief Operating OfficerAug 14Sale134.555,000672,75019,898Aug 15 12:57 PM
PULLINS JERALD LDirectorAug 13Sale134.825,000674,10015,851Aug 15 12:58 PM
Trier ClaytonDirectorAug 13Sale135.193,750506,96310,100Aug 14 02:36 PM
REEVE GRAHAM D.COOAug 12Sale134.00952127,56817,002Aug 13 02:08 PM
MCAFEE LAWRANCE WChief Financial OfficerAug 09Sale131.502,500328,75121,728Aug 12 02:25 PM